Scott D. Sandell - 31 Dec 2025 Form 5 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Reporting relationship: 10%+ Owner
Issuer ticker: TRVI
Reported as of: 31 Dec 2025
Net transaction value: +$2,537,037
SEC form: 5
Accepted by SEC: 13 Feb 2026, 16:30:23 UTC
Prior SEC filing: 06 Oct 2025
Next SEC filing: 05 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Zachary Bambach, attorney-in-fact

Key filing fact

Scott D. Sandell filed Form 5 for Trevi Therapeutics, Inc. (TRVI) on 13 Feb 2026.

Key facts

This page summarizes Scott D. Sandell's Form 5 filing for Trevi Therapeutics, Inc. (TRVI).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Feb 2026, 16:30.

Change

Previous filing in this sequence was filed on 06 Oct 2025.
Current net transaction value: +$2,537,037.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reporting Owners (1)

CIK 0001237289 Primary reporting owner

SANDELL SCOTT D

Relationship: 10%+ Owner
Address: 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM
Signature: /s/ Zachary Bambach, attorney-in-fact
Signature date: 13 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRVI transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $2,537,037
Shares: +1,851,852
Change %: +18%
Price: $1.37
Shares after: 12,273,280
Date: 17 Apr 2025
Ownership: See Note 1
Footnotes: F1

TRVI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 948,948
Date: 31 Dec 2025
Ownership: See Note 2
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRVI transaction Derivative

3.5-Year Common Stock Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: -1,851,852
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Apr 2025
Ownership: See Note 1
Underlying class: Common Stock
Underlying amount: 1,851,852
Exercise price: $1.37
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 16 securities in which the Reporting Person has no pecuniary interest.

Footnote F2

The Reporting Person is a manager of NEA 18 VGE GP, LLC, which is the sole general partner of NEA Partners 18 VGE, L.P. ("NEA Partners 18 VGE"). NEA Partners 18 VGE is the sole general partner of NEA 18 Venture Growth Equity, L.P. ("NEA 18 VGE"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 18 VGE in which the Reporting Person has no pecuniary interest.